Fabry Disease and the Effectiveness of Enzyme Replacement Therapy (ERT) in Left Ventricular Hypertrophy (LVH) Improvement: A Review and Meta-Analysis

Background: Fabry disease is an inherited lysosomal storage disease affecting multiple organs with complications, including cardiomyopathy such as left ventricular hypertrophy (LVH). Enzyme replacement therapy (ERT) has been the main treatment for Fabry patients since 2001. However, the indications...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Chung-Lin, Lin, Shuan-Pei, Niu, Dau-Ming, Lin, Hsiang-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692116/
https://www.ncbi.nlm.nih.gov/pubmed/34975306
http://dx.doi.org/10.7150/ijms.66448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692116/
https://www.ncbi.nlm.nih.gov/pubmed/34975306
http://dx.doi.org/10.7150/ijms.66448

Ejemplares similares